Clinical Trial Update: A Study of Patients Receiving High-Dose Rate Brachytherapy [Phase 2]

View source ↗

Summary

A Phase 2 study of high-dose-rate brachytherapy in patients with cervical cancer, endometrial cancer, esophageal cancer, prostate cancer, and biliary cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cancer
• Cervical Cancer
• Endometrial Cancer
• Esophageal Cancer
• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24